Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.48 is 35% below its 5-year average of 3.84, near the low end of its 5-year range (1.06–31.87).
As of the fiscal period ended Tuesday, June 30, 2026. 21.71% above its 12-month average of 2.04.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.48.
CURRENT RATIO
2.48
CURRENT RATIO AVG TTM
2.04
CURRENT RATIO AVG 3Y
1.79
CURRENT RATIO AVG 5Y
3.84
CURRENT RATIO AVG 10Y
2.44
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+21.71%
CURRENT VS 3Y AVG
+38.58%
CURRENT VS 5Y AVG
-35.47%
CURRENT VS 10Y AVG
+1.69%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 522 covered companies
CURRENT VS SECTOR MEDIAN
-25.92%
vs the sector median at left
Market Cap
$17.13M
Current Ratio
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$15.91M
Current Ratio
1.11
TTM Avg
2.09
3Y Avg
1.19
5Y Avg
1.02
Market Cap
$15.57M
Current Ratio
0.79
TTM Avg
1.41
3Y Avg
2.88
5Y Avg
3.31
Market Cap
$15.35M
Current Ratio
26.25
TTM Avg
8.96
3Y Avg
10.61
5Y Avg
33.19
Market Cap
$15.33M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.57M | 2.48 | 2.04 | 1.79 | 3.84 |
| BioCardia, Inc. (BCDA)vs › | $16.37M | 2.09 | 1.13 | 1.21 | 2.30 |
| Lipocine Inc. (LPCN)vs › | $17.07M | 11.48 | 10.71 | 12.62 | 10.43 |
| Dyadic International, Inc. (DYAI)vs › | $17.13M | 1.65 | 3.34 | 3.94 | 7.05 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | 1.11 | 2.09 | 1.19 | 1.02 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.57M | 0.79 | 1.41 | 2.88 | 3.31 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.35M | 26.25 | 8.96 | 10.61 | 33.19 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.33M | 1.24 | 4.22 | 12.60 | 18.98 |
| Cosmos Health Inc. (COSM)vs › | $18.58M | 1.05 | 0.99 | 1.52 | 1.43 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.87M | 0.20 | 0.34 | 6.34 | 6.11 |
Current Ratio
2.48
Quick Ratio
1.96
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.48 |
| 2026-03-31 | 1.84 |
| 2025-12-31 | 1.98 |
| 2025-09-30 | 2.12 |
| 2025-06-30 | 1.76 |
| 2025-03-31 | 1.70 |
| 2024-12-31 | 1.06 |
| 2024-09-30 | 1.43 |
| 2024-06-30 | 1.63 |
| 2024-03-31 | 1.46 |
| 2023-12-31 | 1.40 |
| 2023-09-30 | 2.60 |
| 2023-06-30 | 3.66 |
| 2023-03-31 | 3.74 |
| 2022-12-31 | 4.38 |
| 2022-09-30 | 6.51 |
| 2022-06-30 | 7.75 |
| 2022-03-31 | 12.99 |
| 2021-12-31 | 12.47 |
| 2021-09-30 | 19.32 |
| 2021-06-30 | 31.87 |
| 2021-03-31 | 51.65 |
| 2020-12-31 | 5.23 |
| 2020-09-30 | 1.18 |
| 2020-06-30 | 1.26 |
| 2020-03-31 | 0.73 |
| 2019-12-31 | 1.07 |
| 2019-09-30 | 2.40 |
| 2019-06-30 | 3.17 |
| 2019-03-31 | 5.94 |
| 2018-12-31 | 5.09 |
| 2018-09-30 | 5.19 |
| 2018-06-30 | 0.70 |
| 2018-03-31 | 0.52 |
| 2017-12-31 | 0.43 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
